Search

everythinglearnresearchcommunity

for

Search:↓

Stress can trigger or worsen alopecia areata.

Laser hair removal is effective for hirsutism when combined with treatment for the underlying causes.

Objective assessment is needed to accurately determine medication use and adherence.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

Hair loss can be an early sign of HIV infection.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Sparse hairs below frontal hairline can indicate early male balding.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

The patient's hair loss was likely not caused by beta blockers but possibly by stress or other factors.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

The document concludes that individualized treatments for hair issues are effective, certain hair changes can indicate neurocutaneous diseases, specific lotions improve skin health, laser hair removal works but needs more study on long-term effects, men's cosmetics are diverse, peeling is effective but can have side effects, and facial pigmentation is often due to overactive skin cells.

Hair changes could indicate neurological diseases and help monitor treatment.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Diagnosing PCOS in teenagers is challenging and should use strict criteria to avoid misdiagnosis and unnecessary worry.

Oestrogens are key for bone growth during puberty in both boys and girls.

Aminopterin strongly suppresses epithelial tissues and can treat certain skin conditions but has significant side effects.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.